Skip to main content

Open Access 23.01.2017 | Letter to the Editors

Unusual case of ATTR amyloidosis with cardiac manifestation and situs inversus totalis

verfasst von: Max Fritschka, Michael Schlegl, Adrian Borges, Mathias Werner, Rolf Gebker, Burkert Pieske, Sebastian Kelle

Erschienen in: Clinical Research in Cardiology | Ausgabe 4/2017

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Sirs:
Dextrocardia is a rare condition and occurs in approximately 0.01% of the general population [1]. The incidence of amyloidosis is estimated at between 5 and 13 per million inhabitants per year [2]. Cardiac involvement occurs in primary (amyloid light-chain, AL) amyloidosis (40–50%), transthyretin (ATTR) amyloidosis (almost all cases) and in rare cases in secondary (amyloid A, AA) amyloidosis [3]. To our knowledge, the coincidence of situs inversus totalis and cardiac ATTR amyloidosis has never been reported before.
We are reporting the case of a 66-year-old male patient with known situs inversus totalis (Fig. 1a) and arterial hypertension who was hospitalized for right-sided angina pectoris with pain radiating into the neck and mandible alongside exertional dyspnea of NYHA class II. Laboratory results showed mildly positive troponin (high sensitivity): 24 ng/l; slightly elevated CK: 196 U/l; elevated NT-proBNP: 3496 ng/l; CKD stage III, creatinine: 1.07 mg/dl, GFR: 46 ml/min CKD-EPI. Urinalysis and other laboratory tests were without any significant pathological findings. The electrocardiogram showed sinus rhythm with low voltage in the limb leads (Fig. 2). A treadmill exercise test documented ventricular runs, triplets and multiple polymorphic extrasystoles under submaximal load without electrocardiographic ST-segment changes. The spirometry including body plethysmography and DLCO showed a restrictive ventilatory disturbance without pathological gas transfer. The transthoracic echocardiogram presented good left ventricular function (LVEF: 59% biplane Simpson), slight hypokinesis in septal basal and medial segments and severe diastolic dysfunction of grade III with intermediate hypertrophy (IVSd: 15 mm) (Fig. 3). The systolic pulmonary artery pressure was measured at 51 mmHg (+CVP) indicating pulmonary hypertension. No significant valvular heart disease was found. Relative apical sparing was seen in the 2D strain analysis which led to the suspicion of cardiac amyloidosis. Cardiac catheterization (Fig. 1b, c) ruled out a coronary artery disease and a left ventricular biopsy was conducted to obtain endomyocardial tissue samples to confirm the diagnosis (Fig. 4). The pathohistological results were positive for a cardiac manifestation of ATTR amyloidosis. Congophilic material was detected in the congo red dye, which could be marked immunohistochemically with transthyretin antibodies. Finally, cardiac MRI could demonstrate the known situs inversus totalis and diffuse myocardial fibrosis (elevated T1-times of around 1400 ms measured with a 3.0 Tesla clinical cardiac MRI scanner) of the inferolateral (medial/basal) left ventricle typical of amyloidosis (Fig. 5). In view of these results, medical therapy with tafamidis, doxycycline (off-label), ursodeoxycholic acid, green tea (off-label) [4], a beta-blocker and diuretics was started.
We report a rare case of ATTR amyloidosis with cardiac manifestation in a patient with situs inversus totalis. There seems to be no reported case of the coincidence of these two rare conditions to date. Yet cases of Kartagener syndrome (situs inversus, chronic sinusitis, and bronchiectasis due to primary ciliary dyskinesia) as an autosomal recessive disorder alongside renal amyloidosis are found in the current literature [5, 6]. Bronchiectasis is a known cause of secondary amyloidosis [79]. In this reported case no signs of proteinuria in the urine analysis or of bronchiectasis were found, with the spirometry showing a restrictive flow volume curve. Cardiac MRI, along with 2D strain evaluation conducted in transthoracic echocardiography or MRI [10] may lead to the non-invasive diagnosis of cardiac amyloidosis, with definite confirmation through endomyocardial biopsy. Yet a recent publication showed that today the diagnosis of ATTR amyloidosis could also be reached in patients without a monoclonal gammopathy using clinical information and bone scintigraphy alone [11], which might make a biopsy for diagnosis dispensable in certain cases in the future.

Acknowledgements

Sebastian Kelle was supported by an unrestricted research grant from Philips Healthcare and received funding from the German Center for Cardiovascular Research (DZHK).

Compliance with ethical standards

Conflict of interest

There is no conflict of interest to declare with regard to this publication.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

Neuer Inhalt

Print-Titel

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Evans WN, Acherman RJ, Collazos JC, Castillo WJ, Rollins RC, Kip KT et al (2010) Dextrocardia: practical clinical points and comments on terminology. Pediatr Cardiol 31(1):1–6CrossRefPubMed Evans WN, Acherman RJ, Collazos JC, Castillo WJ, Rollins RC, Kip KT et al (2010) Dextrocardia: practical clinical points and comments on terminology. Pediatr Cardiol 31(1):1–6CrossRefPubMed
2.
Zurück zum Zitat Nienhuis HL, Bijzet J, Hazenberg BP (2016) The prevalence and management of systemic amyloidosis in western countries. Kidney Dis 2(1):10–19CrossRef Nienhuis HL, Bijzet J, Hazenberg BP (2016) The prevalence and management of systemic amyloidosis in western countries. Kidney Dis 2(1):10–19CrossRef
3.
4.
Zurück zum Zitat aus dem Siepen F, Buss SJ, Andre F, Seitz S, Giannitsis E, Steen H et al (2015) Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study. Clin Res Cardiol Off J Germ Cardiac Soc 104(8):640–647CrossRef aus dem Siepen F, Buss SJ, Andre F, Seitz S, Giannitsis E, Steen H et al (2015) Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study. Clin Res Cardiol Off J Germ Cardiac Soc 104(8):640–647CrossRef
5.
Zurück zum Zitat El Houssni S, Laine M, Bziz A, Alhamany Z, Eddine Bourkadi J, Bayahia R (2015) Renal amyloidosis revealing a Kartagener’s syndrome. Nephrol Ther 11(1):50–52CrossRefPubMed El Houssni S, Laine M, Bziz A, Alhamany Z, Eddine Bourkadi J, Bayahia R (2015) Renal amyloidosis revealing a Kartagener’s syndrome. Nephrol Ther 11(1):50–52CrossRefPubMed
6.
Zurück zum Zitat Katz M, Benzier E, Nangeroni L, Sussman B (1953) Kartagener’s syndrome (situs inversus, bronchiectasis and chronic sinusitis). N Engl J Med 248(17):730–731CrossRefPubMed Katz M, Benzier E, Nangeroni L, Sussman B (1953) Kartagener’s syndrome (situs inversus, bronchiectasis and chronic sinusitis). N Engl J Med 248(17):730–731CrossRefPubMed
7.
Zurück zum Zitat Edwards DF, Patton CS, Kennedy JR (1992) Primary ciliary dyskinesia in the dog. Probl Vet Med 4(2):291–319PubMed Edwards DF, Patton CS, Kennedy JR (1992) Primary ciliary dyskinesia in the dog. Probl Vet Med 4(2):291–319PubMed
8.
Zurück zum Zitat Goldsmith DJ, Roberts IS, Short CD, Mallick NP (1996) Complete clinical remission and subsequent relapse of bronchiectasis-related (AA) amyloid induced nephrotic syndrome. Nephron 74(3):572–576CrossRefPubMed Goldsmith DJ, Roberts IS, Short CD, Mallick NP (1996) Complete clinical remission and subsequent relapse of bronchiectasis-related (AA) amyloid induced nephrotic syndrome. Nephron 74(3):572–576CrossRefPubMed
9.
Zurück zum Zitat Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S et al (2002) A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Renal Assoc 17(11):2003–2005 Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S et al (2002) A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Renal Assoc 17(11):2003–2005
10.
Zurück zum Zitat Riffel JH, Keller MG, Aurich M, Sander Y, Andre F, Giusca S et al (2015) Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach. Clin Res Cardiol Off J German Cardiac Soc 104(7):591–602CrossRef Riffel JH, Keller MG, Aurich M, Sander Y, Andre F, Giusca S et al (2015) Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach. Clin Res Cardiol Off J German Cardiac Soc 104(7):591–602CrossRef
11.
Zurück zum Zitat Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–2412CrossRefPubMed Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–2412CrossRefPubMed
Metadaten
Titel
Unusual case of ATTR amyloidosis with cardiac manifestation and situs inversus totalis
verfasst von
Max Fritschka
Michael Schlegl
Adrian Borges
Mathias Werner
Rolf Gebker
Burkert Pieske
Sebastian Kelle
Publikationsdatum
23.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 4/2017
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1067-9

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.